Rethinking Solid Tumor Profiling: How the MassARRAY Complements NGS to Optimize Testing Throughout the Treatment Journey
Wednesday, November 2nd, 2022 | 9:00 - 9:50 AM MST
Room #221AB
Characterizing the genetic profile of solid tumors upon initial diagnosis is a critical step in determining the appropriate treatment plan. While NGS provides a unique ability to perform broad genetic profiling, it often does not generate the results required to initiate treatment quickly enough. Additionally, sample input challenges may cause the analysis to fail entirely. Many times, this delayed or unavailable genetic information results in sub-optimal treatment. This session will discuss how the MassARRAY technology provides the targeted genetic results specified by treatment guidelines in a timely and reliable manner, even in the presence of limited and/or poor quality samples. Dr. Adrian Box of Alberta Precision Laboratories will share how this technology optimizes solid tumor profiling at all stages of the treatment journey.
An AMP Annual Meeting badge or Corporate Workshop Day badge is needed to attend the workshop.
PRESENTED BY:
Dr. Adrian Box, Alberta Precision Laboratories
